Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru

Authors

  • Jorge Alberto Gomez GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina
  • Maria Mercedes Castrejon GSK Vaccines Latin America, Panamá, Panamá
  • Nicolas Van de Velde GSK Vaccines, Wavre, Belgium

DOI:

https://doi.org/10.3855/jidc.6827

Keywords:

Cost effectiveness, pneumococcal vaccines, Peru

Abstract

This item has no abstract. Follow the links below to access the full text.

Author Biography

Jorge Alberto Gomez, GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina

Senior Healrh Economic ManagerGSK Vaccines, Latin America

Downloads

Published

2015-07-30

How to Cite

1.
Gomez JA, Castrejon MM, Van de Velde N (2015) Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru. J Infect Dev Ctries 9:796–798. doi: 10.3855/jidc.6827

Issue

Section

Letters to the Editor

Similar Articles

You may also start an advanced similarity search for this article.